1.Orsi D, Ferrara S, Siegel S, et al. Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists. Bioorganic & medicinal chemistry. 2023;78:117130. doi:10.1016/j.bmc.2022.117130.